Petros Pechlivanoglou, MSc, PhD
Post Doctoral Fellow
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto
Toronto Health Economics and Technology Assessment (THETA) Collaborative
144 College St
Toronto,
ON
Canada
M5S3M2
Papers:
4K-2
CURRENT TREATMENT FOR CHRONIC HEPATITIS B (CHB): A SYSTEMATIC REVIEW AND A NETWORK META-ANALYSIS
4L-6
A COST-EFFECTIVENESS ANALYSIS OF MINIMAL RESIDUAL DISEASE TESTING FOR THE MANAGEMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
IMPACT OF TELEHOMECARE PROGRAM ON MONITORING PARAMETERS AMONG COPD AND HF PATIENTS
FACTORS AFFECTING THE DELIVERY OF A PHARMACIST-LED MEDICATION REVIEW. EVIDENCE FROM THE MEDSCHECK ANNUAL SERVICE IN ONTARIO
COST-UTILITY ANALYSIS OF ORAL ANTISEPTIC CHLORHEXIDINE IN DECREASING VENTILATOR-ASSOCIATED PNEUMONIA IN INTENSIVE CARE UNITS
AM07
DECISION MODELLING USING R